Investing

Markets analysis: Investors weigh up impact of ‘miracle diet drugs’ on wider economy

Ciaran Callaghan, head of European equity research at Amundi, the French asset manager, said the potential for the market was ‘enormous’

Boxes of the diabetes drug Ozempic. Picture Mario Tama